Paxlovid Is a Fraud, When Will It Be Taken Off the Market?

Video Link

Pfizer’s revenue is expected to reach $101.3 billion in 2022,40 thanks to the COVID jab and Paxlovid ($10 billion from Paxlovid alone) — both of which are frauds. Neither of them actually work as advertised, and both can make matters worse. In the case of Pfizer’s COVID-19 shot, you can still get the disease once you’ve been injected and boosted, and may still transmit the disease to others as well.

Then, when the shots don’t work to prevent infection — and we’ve now seen even five doses won’t prevent infection — Pfizer makes even more money by selling Paxlovid, which in many cases causes rebound! There can be only one reason for why the FDA has not withdrawn both of these drugs, and that is because they’re actually working for Pfizer.

Immunocompromised patients ‘may carry this virus for a very, very long time, and we see that area as a real new opportunity growth area for Paxlovid to do very well, where you may need to take multiple courses.’ ~ Dr. Mikael Dolsten, chief scientist and president of Worldwide Research and Development at Pfizer

Pfizer itself doesn’t view COVID rebound after Paxlovid treatment as a failure; they see it as a successful venture because the more courses needed, the more money they make. As reported by the Kaiser Family Foundation (KFF) in early July 2022:41

“During a recent investor call, a Pfizer official could spin the recent reports that the virus can hide from Paxlovid into good news, predicting that, as with the vaccine, patients may need multiple courses.

Immunocompromised patients ‘may carry this virus for a very, very long time,’ Dr. Mikael Dolsten [chief scientist and President of Worldwide Research and Development at Pfizer42] said in the investor call. ‘And we see that area as a real new opportunity growth area for Paxlovid to do very well, where you may need to take multiple courses.’”

FDA and CDC Are Extensions of the Drug Industry

Pushing a drug that causes COVID rebound does not appear to be in the best interest of public health. Paxlovid is a fraud and should be taken off the market. The fact that the FDA and CDC have focused on Paxlovid, remdesivir and molnupiravir to the exclusion of all others, including older drugs with high rates of effectiveness and superior safety profiles, sends a very disturbing message.

They’ve basically become extensions of the drug industry and have abandoned their original purpose, which is to protect public health — by ensuring the safety and efficacy of drugs, in the case of the FDA,43 and by conducting critical science and data analysis in the case of the CDC.44

Instead, they seem to be doing everything they can to protect Big Pharma profits, even if it costs you your life. Remdesivir, for example, costs between $2,340 and $3,120 depending on your insurance.45 Ivermectin, meanwhile — which has been very effective against COVID and shown to outperform at least 10 other drugs, including Paxlovid46 — costs between $4847 and $9448 for 20 pills depending on your location. The average cost is said to be about $58 per treatment.49

Paxlovid costs $529 per five-day course of treatment,50 and molnupiravir is around $700.51 While not quite as expensive as remdesivir, both are still nearly 10 times costlier than ivermectin, which is more effective. Imagine the billions of dollars we could have saved were it not for our health agencies being so compromised by industry.

Since the FDA and CDC cannot be trusted, it’s imperative to take responsibility for your own health. Do your own research and follow your own conscience and conviction. Remember, when it comes to COVID-19, early treatment is crucial, and effective protocols are readily available — just not from the FDA, CDC or even most hospitals.

For a refresher, check out Dr. Pierre Kory’s interview with Chris Martenson. You can also find many other articles describing treatment protocols by searching through my Substack archive.

Sources and References

1 FDA, October 22, 2020
2 International Journal of Infectious Diseases, 2020; doi: 10.1016/j.ijid.2020.06.093
3 New England Journal of Medicine, 2021;384:497
4 Scientific Freedom, June 1, 2020
5 The Lancet, 2020;395(10236):P1569
6 U.S. FDA December 22, 2021
7, 8 U.S. CDC, COVID-19 Rebound After Paxlovid Treatment May 24, 2022
9, 11, 12 CNN May 31, 2022
10 NEJM September 15, 2022; 387: 1045-1047
13, 14, 16, 19 CNBC July 27, 2022
15 MedRxiv June 22, 2022
17 Yahoo! May 11, 2022
18 Bitchute Jimmy Dore Show August 2, 2022
20 Forbes June 30, 2022
21 CNN June 30, 2022
22 Twitter Joseph Mercola July 21, 2022
23 Politico July 30, 2022
24 Politico August 16, 2022
25 CNN August 29, 2022
26 Twitter Ian Miller October 22, 2022
27 World Freedom Alliance October 23, 2022
28 NY Post October 22, 2022
29 MSN October 31, 2022
30, 31 Bloomberg April 29, 2022 (Archived)
32 Clinical Infectious Diseases June 20, 2022
33 UC San Diego Health June 21, 2022
34, 36 Science June 29, 2022
35, 37, 38 bioRxiv June 7, 2022
39 Revyuh May 1, 2022
40 Fierce Pharma November 21, 2021
41 KHN July 5, 2022
42 Pfizer May 25, 2010
43 FDA Mission
44 CDC Mission
45 AJMC June 29, 2020
46 Cornell University, January 20, 2022
47 WellRx, Ivermectin
48 Ivermectin
49 JAMA 2022;327(6):584-587
50 Precision Vaccinations, November 19, 2021
51 Reuters February 3, 2022

The post Paxlovid Is a Fraud, When Will It Be Taken Off the Market? appeared first on LewRockwell.

Share DeepPol
Generated by Feedzy